Bordetella PertussisInfections in Vaccinated and Unvaccinated Adolescents and Adults, as Assessed in a National Prospective Randomized Acellular Pertussis Vaccine Trial (APERT)
Author(s) -
Joel I. Ward,
James D. Cherry,
SweiJu Chang,
Susan Partridge,
Wendy A. Keitel,
Kathryn M. Edwards,
Martin Lee,
John J. Treanor,
David P. Greenberg,
Stephen J. Barenkamp,
David I. Bernstein,
Robert Edelman
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/504803
Subject(s) - medicine , whooping cough , bordetella pertussis , serology , vaccination , filamentous haemagglutinin adhesin , immunology , pertactin , antibody , pertussis vaccine , pertussis toxin , immunization , biology , genetics , receptor , g protein , bacteria
Acellular pertussis (aP) booster immunizations have been recommended for adolescents and older persons to enhance long-term protection and to possibly reduce community transmission of infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom